In last trading session, CryoPort Inc (NASDAQ:CYRX) saw 0.35 million shares changing hands with its beta currently measuring 1.58. Company’s recent per share price level of $17.48 trading at -$0.58 or -3.21% at ring of the bell on the day assigns it a market valuation of $856.17M. That closing price of CYRX’s stock is at a discount of -38.27% from its 52-week high price of $24.17 and is indicating a premium of 48.51% from its 52-week low price of $9.00. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 0.39 million shares which gives us an average trading volume of 441.02K if we extend that period to 3-months.
CryoPort Inc (NASDAQ:CYRX) trade information
Upright in the red during last session for losing -3.21%, in the last five days CYRX remained trading in the red while hitting it’s week-highest on Tuesday, 04/09/24 when the stock touched $17.48 price level, adding 8.0% to its value on the day. CryoPort Inc’s shares saw a change of 12.85% in year-to-date performance and have moved -4.01% in past 5-day. CryoPort Inc (NASDAQ:CYRX) showed a performance of 21.73% in past 30-days. Number of shares sold short was 4.06 million shares which calculate 6.83 days to cover the short interests.
CryoPort Inc (CYRX) estimates and forecasts
Statistics highlight that CryoPort Inc is scoring comparatively higher than the scores of other players of the relevant industry. The company added 39.06% of value to its shares in past 6 months, showing an annual growth rate of 7.09% while that of industry is -4.00. Apart from that, the company came raising its revenue forecast for fiscal year 2024. The company is estimating its revenue growth to decrease by -118.70% in the current quarter and calculating 21.40% increase in the next quarter. This year revenue growth is estimated to rise 5.30% from the last financial year’s standing.
8 industry analysts have given their estimates about the company’s current quarter revenue by setting an average figure of $58.76 million for the same. And 8 analysts are in estimates of company making revenue of $60.29 million in the next quarter that will end on Jun 2024. Company posted $62.82 million and $59.36 million of sales in current and next quarters respectively a year earlier. Analysts are expecting this quarter sales to shrink by -6.50% while estimating it to be 1.60% for the next quarter.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of -45.48% during past 5 years.
CYRX Dividends
CryoPort Inc is more likely to be releasing its next quarterly report between May 02 and May 06 and investors are confident in the company announcing better current-quarter dividends despite the fact that it has been facing issues arising out of mounting debt.
CryoPort Inc (NASDAQ:CYRX)’s Major holders
Insiders are in possession of 2.54% of company’s total shares while institution are holding 107.67 percent of that, with stock having share float percentage of 110.47%. Investors also watch the number of corporate investors in a company very closely, which is 107.67% institutions for CryoPort Inc that are currently holding shares of the company. Brown Capital Management, LLC is the top institutional holder at CYRX for having 7.7 million shares of worth $132.89 million. And as of Jun 29, 2023, it was holding 15.76% of the company’s outstanding shares.
The second largest institutional holder is Vanguard Group Inc, which was holding about 3.49 million shares on Jun 29, 2023. The number of shares represents firm’s hold over 7.13% of outstanding shares, having a total worth of $60.12 million.
On the other hand, Brown Capital Management Small Company Fund and Alger Small Cap Focus Fund are the top two Mutual Funds which own company’s shares. As of Jun 29, 2023, the former fund manager was holding 4.46 million shares of worth $76.91 million or 9.12% of the total outstanding shares. The later fund manager was in possession of 1.93 million shares on Jul 30, 2023, making its stake of worth around $31.01 million in the company or a holder of 3.95% of company’s stock.
